Research graph
References from Eighteen-month real-world outcomes of intravitreal aflibercept 8 mg in treatment-naïve neovascular age-related macular degeneration: a UK single-centre experience. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/s2214-109x(13)70145-1
10.1016/s2214-109x(13)70145-1 · 2014 · External reference
10.1001/jama.2023.26074
10.1001/jama.2023.26074 · 2024 · External reference
10.1056/nejmcp2102061
10.1056/nejmcp2102061 · 2021 · External reference
10.1136/bjophthalmol-2014-305702
10.1136/bjophthalmol-2014-305702 · 2014 · External reference
10.1016/j.ophtha.2012.09.006
10.1016/j.ophtha.2012.09.006 · 2012 · External reference
10.1080/13548506.2016.1274040
10.1080/13548506.2016.1274040 · 2018 · External reference
10.1038/s41433-024-03218-7
10.1038/s41433-024-03218-7 · 2024 · External reference
10.1016/j.xops.2025.100744
10.1016/j.xops.2025.100744 · 2025 · External reference
10.1159/000502747
10.1159/000502747 · 2020 · External reference
10.1001/jamaophthalmol.2023.2421
10.1001/jamaophthalmol.2023.2421 · 2023 · External reference
10.1016/j.ophtha.2025.08.022
10.1016/j.ophtha.2025.08.022 · 2026 · External reference
10.1186/s40942-025-00665-6
10.1186/s40942-025-00665-6 · 2025 · External reference
10.1136/bmjophth-2024-002091
10.1136/bmjophth-2024-002091 · 2025 · External reference
10.1007/s40123-025-01305-w
10.1007/s40123-025-01305-w · 2026 · External reference
10.1016/j.ophtha.2019.11.004
10.1016/j.ophtha.2019.11.004 · 2020 · External reference
10.1038/s41433-022-02231-y
10.1038/s41433-022-02231-y · 2023 · External reference
10.1038/s41433-025-03765-7
10.1038/s41433-025-03765-7 · 2025 · External reference
10.7759/cureus.88617
10.7759/cureus.88617 · 2025 · External reference
